BOEHRINGER INGELHEIM ESPANA has a total of 13 patent applications. Its first patent ever was published in 1991. It filed its patents most often in Spain, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are CHENGDU DI AO JIUHONG PHARMACE, SALK INST BIOLOGICAL STUDIES and NAT HEALTH RESEARCH INSTITUTES.
# | Country | Total Patents | |
---|---|---|---|
#1 | Spain | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | Australia | 1 | |
#5 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Heterocyclic compounds | |
#4 | Microorganisms | |
#5 | Peptides | |
#6 | Fermentation |
# | Name | Total Patents |
---|---|---|
#1 | Gimenez Gallego Guillermo | 4 |
#2 | Cuevas Sanchez Pedro | 2 |
#3 | Sanchez Pedro Cuevas | 2 |
#4 | Camps Garcia Pelayo | 1 |
#5 | Cicconi De Vidal Marta Noemi | 1 |
#6 | Fornell Montserrat Simon | 1 |
#7 | Avarez Luis | 1 |
#8 | Pujol Maria Dolores | 1 |
#9 | Blanco Abilla Gerardo | 1 |
#10 | Banos Josep E | 1 |
Publication | Filing date | Title |
---|---|---|
WO2014187822A1 | Method for the reduction of pcv-2 in a herd of swine | |
ES2162561A1 | Pharmaceutical composition of oral, liquid, transparent, stable and acceptable flavor metamizol. | |
ES2115553A1 | Method to detect the presence of dna polymorphisms, test kit and corresponding recombinant nucleic acids. | |
ES2075810A1 | Pharmacological use of the fibroblast growth factor and its derivatives in neurodegenerative diseases. | |
EP0647712A1 | Production of S-adenosyl-methionine (SAM) by fermentation of transformed bacteria | |
ES2061380A1 | Employment of the fibroblastic growth factor and its derivatives as neuroprotectors and neuromodulators. | |
ES2042384A1 | Procedure for obtaining bis-pyridine derivatives. | |
ES2029774A6 | Improved acidic fibroblast growth factor (aFGF) and its preparation. |